ANI Pharmaceuticals $316.25 million convertible notes offering
We advised ANI Pharmaceuticals on the offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Penumbra $100 million accelerated share repurchase
We advised Penumbra on the ASR transaction
Alkami Technology $155.9 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Fiserv $1.75 billion notes offering
The investment-grade debt consists of two tranches of notes
Enova International $500 million notes offering and concurrent tender offer
The high-yield notes are due 2029
Walgreens Boots Alliance $750 million notes offering
We advised Walgreens Boots Alliance on its debt offering
Ninth Circuit affirms dismissal for Lucid Motors, limits Section 10(b) standing
We secured a complete victory for Lucid
CytomX Therapeutics $58.3 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Precigen $34 million follow-on offering
We advised Precigen on the SEC-registered offering
PPL Capital Funding $750 million senior notes offering
The 5.250% investment-grade senior notes are due 2034